TimesSquare Capital Management LLC Has $75.85 Million Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

TimesSquare Capital Management LLC boosted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 9.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 476,217 shares of the company's stock after acquiring an additional 42,411 shares during the period. Inspire Medical Systems makes up approximately 1.2% of TimesSquare Capital Management LLC's holdings, making the stock its 23rd largest holding. TimesSquare Capital Management LLC owned approximately 1.60% of Inspire Medical Systems worth $75,852,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Huntington National Bank raised its position in Inspire Medical Systems by 228.3% in the fourth quarter. Huntington National Bank now owns 174 shares of the company's stock worth $32,000 after purchasing an additional 121 shares in the last quarter. True Wealth Design LLC raised its holdings in shares of Inspire Medical Systems by 39.0% in the 4th quarter. True Wealth Design LLC now owns 196 shares of the company's stock worth $36,000 after buying an additional 55 shares in the last quarter. Harbour Investments Inc. lifted its position in shares of Inspire Medical Systems by 101.0% during the 4th quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after buying an additional 99 shares during the period. Parallel Advisors LLC boosted its stake in Inspire Medical Systems by 356.5% in the 1st quarter. Parallel Advisors LLC now owns 210 shares of the company's stock valued at $33,000 after buying an additional 164 shares in the last quarter. Finally, AlphaQuest LLC grew its position in Inspire Medical Systems by 7,275.0% in the fourth quarter. AlphaQuest LLC now owns 295 shares of the company's stock valued at $55,000 after acquiring an additional 291 shares during the period. Institutional investors and hedge funds own 94.91% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Wall Street Zen raised Inspire Medical Systems from a "hold" rating to a "buy" rating in a report on Saturday, July 12th. Stifel Nicolaus cut their price target on shares of Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a report on Monday, April 21st. Morgan Stanley decreased their price objective on shares of Inspire Medical Systems from $200.00 to $182.00 and set an "overweight" rating on the stock in a research note on Tuesday. KeyCorp dropped their price objective on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, Royal Bank Of Canada reduced their target price on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a report on Tuesday, April 15th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $210.27.

Inspire Medical Systems Stock Performance

NYSE:INSP traded up $0.71 on Thursday, hitting $128.21. 631,234 shares of the stock were exchanged, compared to its average volume of 559,657. Inspire Medical Systems, Inc. has a 52 week low of $123.00 and a 52 week high of $225.00. The stock has a market capitalization of $3.78 billion, a price-to-earnings ratio of 59.08, a P/E/G ratio of 1.95 and a beta of 1.25. The company's 50-day moving average price is $136.73 and its 200 day moving average price is $160.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $0.10 EPS for the quarter, topping the consensus estimate of ($0.23) by $0.33. Inspire Medical Systems had a net margin of 7.92% and a return on equity of 10.00%. The company had revenue of $201.32 million during the quarter, compared to analysts' expectations of $194.89 million. During the same quarter in the previous year, the company earned ($0.34) EPS. Inspire Medical Systems's revenue was up 22.7% on a year-over-year basis. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current year.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 360 shares of the firm's stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $160.00, for a total transaction of $57,600.00. Following the transaction, the director owned 24,046 shares in the company, valued at approximately $3,847,360. This trade represents a 1.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 4.10% of the stock is currently owned by company insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.